Source: BIOPORTFOLIO

Sharp Edge: Sharp Edge Labs and Creagen Biosciences Enter Drug Discovery Collaboration

Agreement could bring new treatments for diseases including Parkinsons Alzheimers and Cystic Fibrosis.Pittsburgh PA and Woburn MA PRWEB September 09 2015 Sharp Edge Labs Inc. httpwww.sharpedgelabs.com a drug discovery biology firm and Creagen Biosciences...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Scott F Sneddon's photo - President & CEO of Sharp Edge

President & CEO

Scott F Sneddon

CEO Approval Rating

83/100

Read more